Effect of COVİD-19 pandemic and coronavac vaccine on blood pressure regulation in chronic hypertensive patients

Basit Öğe Kaydı
dc.contributor.authorŞenöz, Oktay
dc.contributor.authorErseçgin, Ahmet
dc.contributor.authorDemir, Yusuf
dc.contributor.authorYurdam, Ferhat Siyamend
dc.contributor.authorYapan Emren, Zeynep
dc.contributor.authorGürses, Ecem
dc.date.accessioned2023-03-22T19:48:24Z
dc.date.available2023-03-22T19:48:24Z
dc.date.issued2021
dc.departmentBelirleneceken_US
dc.description.abstractObjective: The most common comorbidity in patients with Covid-19 infection is hypertension. Apart from the direct effects of the virus on hypertensive patients, the pandemic period also negatively affected these patients. In addition, the effect of the newly discovered CoronaVac vaccine, which has been widely used in our country in recent months for the prevention of covid-19 infection, on blood pressure regulation is unknown. In this study, we aimed to investigate the effects of the pandemic period and the CoronaVac vaccine in patients receiving treatment for essential hypertension.Method: One hundred ninety-six patients who applied to the cardiology outpatient clinic between 4 June - 9 July 2021, were treated for essential hypertension and had at least 1 dose of CoronaVac vaccine were included in the study. In the pre-pandemic, pre-vaccine and post-vaccine period, mean home and office blood pressures of the patients were examined separately. Results: While the mean home blood pressures of the patients differed significantly between the pre-pandemic and pre-vaccine pandemic period (systolic: 125.1±12.6 vs 129.1±14.1 mmhg, p<0.001, diastolic: 75.3±9.7 vs 77.1±9.8 mmhg, p=0.004), there was no significant difference between the pre- and post-vaccination period (systolic: 129.1±14.1 vs 129.7±13.7 mmhg, p=0.229, diastolic: 77.1±9.8 vs 77.9±9.9 mmhg, p=0.091). Similarly, while office blood pressures differed significantly between the pre-pandemic and pre-vaccine pandemic period (systolic: 133.5±16.5 vs 136.1±16.4 mmhg, p=0.015, diastolic: 79.4±10.9 vs 81.2±12.1 mmhg, p=0.036), there was no significant difference between the pre- and post-vaccination period (systolic: 136.1±16.4 vs 135.6±16.9 mmhg, p=0.651, diastolic: 81.2±12.1 vs 81.1±11.2mmhg, p=0.914). Conclusion: While the Covid-19 pandemic increased the blood pressure of chronic hypertensive patients, the CoronaVac vaccine did not affect the blood pressure regulation of these patients.en_US
dc.identifier.endpage7en_US
dc.identifier.issn2148-0990
dc.identifier.issue3en_US
dc.identifier.startpage1en_US
dc.identifier.trdizinid486847en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14034/1083
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/486847
dc.identifier.volume59en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.journalEge Klinikleri Tıp Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEffect of COVİD-19 pandemic and coronavac vaccine on blood pressure regulation in chronic hypertensive patientsen_US
dc.typeOtheren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Effect of COVİD-19 pandemic and coronavac vaccine on blood pressure regulation in chronic hypertensive patients.pdf
Boyut:
886.38 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu